Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells

Shinong Wang1, Raimund Hirschberg

  • 1Harbor-UCLA Research and Education Institute, UCLA, Torrance, California 90502, USA.

Insights

Bone morphogenetic protein-7 (BMP7) opposes kidney fibrosis by inhibiting transforming growth factor beta (TGF-β) signaling. This study reveals BMP7 utilizes Smad5 and Smad6 to block TGF-β-induced fibrogenesis in mesangial cells.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Biology

Background:

  • Bone morphogenetic protein-7 (BMP7) is present in adult kidneys and mitigates renal fibrogenesis in rodent models.
  • BMP7 inhibits transforming growth factor beta (TGF-β)-driven fibrosis in mesangial cells by affecting matrix degradation and PAI-1 regulation.

Purpose of the Study:

  • To elucidate the signaling pathways and mechanisms by which BMP7 counteracts TGF-β actions in mesangial cells.
  • To investigate the role of Smad proteins in BMP7's anti-fibrotic effects.

Main Methods:

  • Utilized mesangial cells to study BMP7 and TGF-β signaling.
  • Performed Smad5 knockdown experiments.
  • Assessed transcriptional activation using CAGA-lux reporter assays.
  • Measured PAI-1 levels and nuclear Smad accumulation.

Main Results:

  • BMP7 reduced nuclear Smad3 accumulation and blocked TGF-β-induced CAGA-lux activation.
  • Smad5 knockdown impaired BMP7's ability to inhibit TGF-β-induced CAGA-lux activation and PAI-1 accumulation.
  • Smad5 knockdown reduced BMP7-induced Smad6 expression.
  • Forced expression of Smad5 or Smad6 mimicked BMP7's inhibitory effects on TGF-β-induced PAI-1 activation and secretion.

Conclusions:

  • A model is proposed where BMP7 opposes TGF-β-dependent mesangial fibrogenesis via Smad5 and the downstream inhibitory Smad6.
  • BMP7 reduces nuclear Smad3 availability and requires Smad5 signaling.
  • BMP7's mechanism does not involve Erk1/2, p38, JNK, Ski, or SnoN in mesangial cells.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...